secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLESENCE, INC. (SLSN)
CIK:        0000883107
Form:       8-K
Filed at:   2026-10-02T20:00:15+00:00
Accession:  0001171843-26-006367
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Solésence receives Nasdaq bid-price deficiency notice; has until March 29, 2027 to regain $1.00 compliance
--------------------------------------------------------------------------------

- Nasdaq Listing Qualifications notice dated September 29, 2026: SLSN closing bid price fell below $1.00 per share for 30 consecutive trading days, breaching Listing Rule 5550(a)(2).
- Company has a 180-calendar-day initial compliance period ending March 29, 2027; cure requires a closing bid of at least $1.00 for a minimum of 10 consecutive trading days.
- If not cured by March 29, 2027, Solésence may qualify for an additional 180 days by meeting the market value of publicly held shares and all other Capital Market initial-listing standards.
- Company says it is evaluating various courses of action; warns that non-compliance or delisting would materially and adversely affect its ability to raise capital and its financial condition.
- Notice has no immediate effect on the listing of the common stock on Nasdaq Capital Market; CFO Laura Riffner signed the report dated October 2, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883107/000117184326006367/0001171843-26-006367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883107/000117184326006367/f8k_100226.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-006367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer